NCT03585569View on ClinicalTrials.gov

" Treating MS Patients With Lower Extremity Spasticity Using Dysport"

PHASE3UnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

May 31, 2019

Study Completion Date

May 31, 2020

Conditions
Multiple SclerosisSpasticity, Muscle
Interventions
BIOLOGICAL

Abobotulinumtoxin A

Treating Patients with Multiple Sclerosis with lower extremity spasticity using Dysport (Abobotulinumtoxin A)

Trial Locations (1)

02035

RECRUITING

Neurology Center of New England P.C., Foxborough

Sponsors

Collaborators (1)

Ipsen
All Listed Sponsors
collaborator

Ipsen

INDUSTRY

lead

Neurology Center of New England P.C.

OTHER